INTS vs NWS
Intensity Therapeutics, Inc. Common stock (INTS) versus NWS (NWS) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
NWS (NWS) common stock.
INTS does not have a complete income-statement cache yet.
Latest reported NWS revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 6.8% from 2025-06-30 to 2026-06-30. NWS currently screens at market cap $0.
INTS currently screens at market cap $7.7M. NWS currently screens at market cap $0.
Not investment advice. Open the INTS and NWS stock pages for the full models.
Not investment advice.